JP Morgan Chase
AUXL

JP Morgan Chase’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

JP Morgan Chase’s Portfolio AUXL Stock Details AUXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-133,882
Closed -$4M – 4516
2014
Q3 		$4M Sell
133,882
-55,248
-29% -$1.17M ﹤0.01% 2509
2014
Q2 		$3.79M Sell
189,130
-24,085
-11% -$552K ﹤0.01% 2213
2014
Q1 		$5.8M Sell
213,215
-60,517
-22% -$1.61M ﹤0.01% 1998
2013
Q4 		$5.67M Buy
273,732
+2,208
+0.8% +$41.6K ﹤0.01% 2093
2013
Q3 		$4.94M Buy
271,524
+5,830
+2% +$105K ﹤0.01% 2193
2013
Q2 		$4.42M Buy
+265,694
New +$4.24M ﹤0.01% 2220

Other funds holding AUXL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
MP
Manikay Partners New York $893M AUM 55.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase's AUXL Position: Q4 2014 in Review

JP Morgan Chase sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q4 2014, closing a stake of 133,882 shares — an estimated $4M sold.

JP Morgan Chase first reported a position in AUXL in Q2 2013 and held it in 6 quarters. The position peaked at $5.8M in Q1 2014. 158 funds tracked by Wall St. Rank hold AUXL as of Q4 2014.

  • JP Morgan Chase reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q4 2014 after selling out during the quarter.
  • JP Morgan Chase sold 133,882 AUXILIUM PHARAMCEUTICALS INC shares in Q4 2014, an estimated $4M.
  • JP Morgan Chase first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 6 quarters.
  • JP Morgan Chase's AUXILIUM PHARAMCEUTICALS INC position peaked at $5.8M in Q1 2014.
  • 158 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q4 2014.

Based on JP Morgan Chase's 13F filing for Q4 2014, filed 13 Feb 2015.